Paper Details

  1. Home
  2. Paper Details

Chemotherapy versus best supportive care for extensive small cell lung cancer.

Author: Bonfill CospXavier, Cortés-JofréMarcela, Pelayo AlvarezMarta, WesteelVirginie

ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Combination chemotherapy, despite only modestly extending median survival time, remains the mainstay treatment for extensive stage small cell lung cancer (SCLC) over the past 30 years. Palliative care is crucial for improving quality of life in these patients.
Paper Details　
Original Abstract of the Article :
Combination chemotherapy has been the mainstay of treatment for extensive stage small celI lung cancer (SCLC) over the last 30 years, even though it only gives a short prolongation in median survival time. The main goal for these patients should be palliation with the aim of improving their quality ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1002/14651858.CD001990.pub3

データ提供：米国国立医学図書館（NLM）

Extensive Small Cell Lung Cancer: Prioritizing Palliative Care

Extensive small cell lung cancer (SCLC) is a highly aggressive form of lung cancer with a poor prognosis. This study examines the role of chemotherapy in managing extensive SCLC, considering the limitations of this treatment approach. Researchers discuss the traditional use of combination chemotherapy for extensive SCLC, despite its limited impact on overall survival. They argue that the primary focus for patients with extensive SCLC should be palliative care, aiming to improve quality of life and manage symptoms.

Palliative Care: A Central Focus in Extensive SCLC

The study suggests that [combination chemotherapy] may not provide significant survival benefits for patients with extensive SCLC. This highlights the need for a paradigm shift towards prioritizing palliative care, focusing on symptom management, quality of life, and patient well-being. This approach acknowledges the limitations of chemotherapy in this advanced stage of cancer and prioritizes the needs of the patient.

Navigating the Difficult Journey of Advanced Lung Cancer

This study underscores the importance of a compassionate and holistic approach to managing advanced lung cancer. While chemotherapy may play a role in symptom management, palliative care should be the primary focus, ensuring patient comfort and dignity. This research emphasizes the need for supportive care and open communication with patients and their families, providing guidance and support throughout the challenging journey of advanced lung cancer.

Dr.Camel's Conclusion

Like a camel enduring the harsh conditions of the desert, patients with extensive SCLC face a challenging journey. This study highlights the need for a compassionate and supportive approach, prioritizing palliative care to improve quality of life and manage symptoms. This research underscores the importance of focusing on patient well-being and providing comprehensive care throughout the course of this difficult disease.

Date :
  1. Date Completed 2014-05-20
  2. Date Revised 2022-04-19
Further Info :

Pubmed ID

24282143

DOI: Digital Object Identifier

10.1002/14651858.CD001990.pub3

Related Literature

Article Analysis
・Effective treatment of lung cancer
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.